CBD is a doping product banned in sport
CBD is not a performance-enhancing substance so why ban it? In 1998, Ross Rebagliati, a Canadian snowboarder, tested positive for THC during the competition. This prompted the Olympic authorities to add cannabis and all its cannabinoids to the list of banned substances.
But since then, a lot has changed…
In 2013, the committee quietly increased the rate of THC allowed for an athlete during the competition.
In 2016, they changed again to a limit that means athletes can use cannabis, as long as they stop using cannabis a few weeks before the competition.
In 2018, the rules have not changed for THC but the World Anti-Doping Agency (WADA) has finally authorized the consumption of THC-free CBD products for athletes before, after and even during competition. This means that a runner will be able to apply a product to the CBD on his leg just before the race.
CBD-based products have the same effects as recreational cannabis
Lorsqu’en When in 1753 the Swedish botanist Carl von Linné invented our plant classification system, he used the Esperanto of the time : Latin. He calls hemp Cannabis Sativa L, that is, cultivated hemp (L means “cultivated” according to Linné).
The words “hemp” and “cannabis” – one French, the other Latin – are therefore, in principle, interchangeable. However, in 1961, hemp was classified by international conventions as “narcotics without medical interest”. Since then, the word “cannabis” has taken on a particular connotation, as if there were two different plants – as if there were a “good” textile hemp side, and on the other hand, the “bad” psychotropic cannabis.
However, all natural varieties of hemp/cannabis contain, in very different proportions, a resistant fiber (in the stem), a great nutritional richness (in the seed), psychoactive and therapeutic principles (in flowers). All varieties are similar (it is impossible to distinguish them with the naked eye) and all hybridize with each other.
We’re forced to smoke CBD
CBD can be purchased in a variety of forms. Flowers, infusions, oils, capsules in absorption or application. At CORELL, we attach importance to making no incentive to smoke because all fumes contain many compounds that are irritating or toxic for the lungs.
This is why different alternative absorption methods – including vaporizers – are becoming more and more common. Absorption by the lungs offers an immediate effect including vaporization. They heat the previously ground plant material to an optimal temperature of 178 degrees Celsius (it must not drop below 130 degrees Celsius or rise above 225 degrees Celsius). At this temperature, there is no combustion so no smoke and no toxic tars are released.
Instead of burning, active ingredients are “sprayed”, that is, transformed into an inhalable aerosol. You can find our recommended vaporizer in our accessories section.
CBD-based products with 0% THC are necessarily chemicals
Not at CORELL. To obtain a CBD product without THC, organic Rapeseed oil, rich in omega 3+6+9, is mixed with CBD isolate. Isolate is not a chemical! CBD isolate is simply the purest form of CBD. It is extracted using different methods from the plant in the form of crystals and then reduced to powder.
Cannabis in a few figures
- 800 varieties of cannabis
- 500 identified components of which 66 are not found anywhere else called cannabinoids, flavonoids and terpenes. No alkaloids unlike other drugs that are toxic and deadly.
- 10 000 years of use
The CBD in pictures…
A quick overview of the potential effects and virtues of CBD according to scientific studies conducted so far and still ongoing.
Our human body and its endogenous cannabinoid system :
The human body has an endogenous cannabinoid system. This system consists of :
- Endocannabinoids (varieties of endogenous substance, kind of a natural messenger. They transmit information about the state of the body both in the brain and in other organs, causing reactions at the cell level. There are 200 varieties of endogenous substances).
- Cannabinoid receptors (specific sites on the surface of cells. See diagram below).
Thus, the natural cannabinoids of hemp are interactive and act on the body in a similar way to endocannabinoids that perform a multitude of functions in the human body.
The effects of CBD
Below, we will report, summarize (see list of sources) comments and studies on the potential effects of cannabis, specifically on the potential effects of CBD.
Of course, this list is not exhaustive and other scientific studies are underway on the ailments and pathologies that we have just outlined. This will add to your knowledge of the supposed virtues of CBD.
Why does it work ?
- Dr Franjo Grottenhermen and his book « guide pratique des applications thérapeuthiques du cannabis, THC et CBD ».
- Michka and her book : Cannabis médical.
- Aran, A. , Cassuto, H. , Lubotzky, A. , Wattad, N. & Hazan, E. (2018). Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study. Journal of Autism and Developmental Disorders, 1-5.
- Burstein, S. (2015), Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & Medicinal Chemistry, 23, 137-1385.
- Campos, A. C., Fogaça, M. V., Sonego, A. B. & Guimarães, F. S. (2016). Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacological Research, 112, 119-127.
- Grotenhermen, F. & Müller-Vahl, K. (2017). Medicinal Uses of marijuana and Cannabinoids. Critical Reviews in Plant Sciences, 35(5-6), 378-405.
- Hahn, B. (2017). The Potential of Cannabidiol Treatment for Cannabis Users With Recent-onset Psychosis. Schizophrenia Bulletin, 1-8. doi: 10.1093/schbul/sbx105
- Iffland, K. & grotenhermen, F. (20179. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis and Cannabinoid Research, 2(1), 139-154.
- Marthaler, M. Udrisard, R. und Zobel, F. (2016). Rekrutierung von Teilnehmenden für die europäische online Drogenbefragung. Lausanne: Sucht Schweiz.
- Morabito, D., Soyster, P., Ramey-Wright, S., Belendiuk, K. A. & Bonn-Miller, M. O. (2016). A Review of Recent Advances in the Therapeutic Uses of Secondary Cannabinoids. Current Addiction Reports, 3, 230- 238.
- National Academies of Sciences, Engineering, and Medicine (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. doi:10.17226/24625.
- Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163, 1344-1364.
- Russo, E. B. (2017). Cannabidiol Claims and Misconceptions. Trends in Pharmacological Sciences, 38(3), 198-201.
- Volkow, N. D. (2015, juin). The biology and potential therapeutic effect of cannabidiol. Senate Caucus on International Narcotics Control.
- Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M. & Kleijnen, J. (2015). Cannabinoids for medical Use: A systematic review and meta-analysis. JAMA, 313(24), 2456-2473.